News | April 08, 2025
NATCO Pharma updates on legal proceedings on Risdiplam launch in India
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Findings likely to generate hypotheses about potential new uses of drugs
Increases Siemens’ industrial software total addressable market by $11 billion; aligns with strategic goal to accelerate customer innovation across industries
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
The company expects to launch this product through its marketing partner in the near future
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle AD study
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Awards highlight Avantor's commitment to the Biopharma industry
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Subscribe To Our Newsletter & Stay Updated
